St. Jude nets clearance for leads in Japan

St. Jude Medical has received regulatory and reimbursement approvals for its Durata high-voltage defibrillation lead from the Japanese Ministry of Health, Labour and Welfare.

The St. Paul, Minn.-based company said its Durata lead incorporates a soft silicone tip with a larger surface area and a slightly curved right ventricle shock coil. The Durata lead also incorporates Optim insulation, a hybrid insulation material unique to St. Jude and created for cardiac leads. 

The company said its Durata leads have flatwire technology with silicone backfill to prevent tissue in-growth; dual, redundant cables designed to increase reliability; and single- and dual-coil design with 17-cm and 21-cm shock coil spacing.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.